Multigene assays for late recurrence of breast cancer

被引：2
|
作者：
Ignatiadis, Michail [1 ,2 ]
机构：
[1] Univ Libre Brussels, Inst Jules Bordet, Dept Med Oncol, B-1000 Brussels, Belgium
[2] Univ Libre Brussels, Inst Jules Bordet, Breast Canc Translat Res Lab, B-1000 Brussels, Belgium
来源：
LANCET ONCOLOGY | 2013年 / 14卷 / 11期
关键词：
RISK;
D O I：
10.1016/S1470-2045(13)70437-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1029 / 1030
页数：3
相关论文
共 50 条
  • [41] Evaluation of Multigene Assays as Predictors for Response to Neoadjuvant Chemotherapy in Early-Stage Breast Cancer Patients
    Freeman, Jincong Q.
    Shubeck, Sarah
    Howard, Frederick M.
    Chen, Nan
    Nanda, Rita
    Huo, Dezheng
    CANCER RESEARCH, 2023, 83 (05)
  • [42] Evaluation of multigene assays as predictors for response to neoadjuvant chemotherapy in early-stage breast cancer patients
    Jincong Q. Freeman
    Sarah Shubeck
    Frederick M. Howard
    Nan Chen
    Rita Nanda
    Dezheng Huo
    npj Breast Cancer, 9
  • [43] Late local breast cancer recurrence: a single center experience
    Khaldi, Oumeima
    Saadallah, Fatma
    Ben Ltaief, Sarra
    Kammoun, Salma
    Zemni, Ines
    Dhieb, Tarek
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A144 - A145
  • [44] Evaluation of multigene assays as predictors for response to neoadjuvant chemotherapy in early-stage breast cancer patients
    Freeman, Jincong Q. Q.
    Shubeck, Sarah
    Howard, Frederick M. M.
    Chen, Nan
    Nanda, Rita
    Huo, Dezheng
    NPJ BREAST CANCER, 2023, 9 (01)
  • [45] Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence
    Howard, Frederick M.
    Dolezal, James
    Kochanny, Sara
    Khramtsova, Galina
    Vickery, Jasmine
    Srisuwananukorn, Andrew
    Woodard, Anna
    Chen, Nan
    Nanda, Rita
    Perou, Charles M.
    Olopade, Olufunmilayo I.
    Huo, Dezheng
    Pearson, Alexander T.
    NPJ BREAST CANCER, 2023, 9 (01)
  • [46] Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence
    Frederick M. Howard
    James Dolezal
    Sara Kochanny
    Galina Khramtsova
    Jasmine Vickery
    Andrew Srisuwananukorn
    Anna Woodard
    Nan Chen
    Rita Nanda
    Charles M. Perou
    Olufunmilayo I. Olopade
    Dezheng Huo
    Alexander T. Pearson
    npj Breast Cancer, 9
  • [47] LATE RECURRENCE OF CARCINOMA OF BREAST
    SUTTON, M
    BMJ-BRITISH MEDICAL JOURNAL, 1960, 2 (OCT15): : 1132 - 1134
  • [48] ASSOCIATION OF SOCIOECONOMIC POSITION AND RACIAL DISPARITIES IN MULTIGENE PROGNOSTIC SCORE MEASURING BREAST CANCER RECURRENCE RISK
    Zolekar, A.
    Kong, A.
    Lee, T. A.
    Kim, K.
    Nutescu, E. A.
    Calip, G. S.
    VALUE IN HEALTH, 2023, 26 (06) : S177 - S178
  • [49] From microarray to RT-qPCR for a multigene panel to predict the risk of breast cancer recurrence.
    Cheng, Skye Hung-Chun
    Huang, Tzu-Ting
    Chu, Nei-Min
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Prediction of early and late distant recurrence in early-stage breast cancer with Breast Cancer Index
    Zhang, Yi
    Schnabel, Catherine A.
    Schroeder, Brock
    Jerevall, Piiha-Lotta
    Jankowitz, Rachel Catherine
    Stal, Olle
    Brufsky, Adam
    Sgroi, Dennis
    Erlander, Mark G.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345